ELATIA Trademark

Trademark Overview

On Friday, September 21, 2012, a trademark application was filed for ELATIA with the United States Patent and Trademark Office. The USPTO has given the ELATIA trademark a serial number of 85734802. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 10, 2017. This trademark is owned by Glaxo Group Limited. The ELATIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; Vaccines; All of the foregoing excluding pharmaceutical preparations for treatment of neurological-related diseases and disorders
elatia

General Information

Serial Number85734802
Word MarkELATIA
Filing DateFriday, September 21, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 10, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 11, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; Vaccines; All of the foregoing excluding pharmaceutical preparations for treatment of neurological-related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 25, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Monday, April 10, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 10, 2017ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 17, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 16, 2016EXTENSION 4 GRANTED
Monday, August 15, 2016EXTENSION 4 FILED
Monday, August 15, 2016TEAS EXTENSION RECEIVED
Tuesday, March 22, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 21, 2016EXTENSION 3 GRANTED
Thursday, February 11, 2016EXTENSION 3 FILED
Friday, March 18, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 11, 2016TEAS EXTENSION RECEIVED
Tuesday, August 18, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 17, 2015EXTENSION 2 GRANTED
Wednesday, July 29, 2015EXTENSION 2 FILED
Friday, August 14, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 29, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 4, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 2, 2015EXTENSION 1 GRANTED
Monday, March 2, 2015EXTENSION 1 FILED
Monday, March 2, 2015TEAS EXTENSION RECEIVED
Tuesday, September 9, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 25, 2014EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, April 23, 2014CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Wednesday, April 23, 2014ASSIGNED TO PETITION STAFF
Tuesday, April 22, 2014TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, April 7, 2014EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, March 11, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 11, 2014PUBLISHED FOR OPPOSITION
Wednesday, February 19, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 3, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, February 3, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 3, 2014LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, July 29, 2013REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, July 26, 2013ASSIGNED TO LIE
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 23, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, January 23, 2013LETTER OF SUSPENSION E-MAILED
Wednesday, January 23, 2013SUSPENSION LETTER WRITTEN
Tuesday, January 15, 2013ASSIGNED TO EXAMINER
Tuesday, September 25, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 25, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

elatia treatment pharmaceutical preparations diseases disorders substances related respiratory gastrointestinal ophthalmic